Back to results
US 2018/0252726 A1Published application
Methods and reagents for analyzing protein-protein interfaces
AssigneeWarp Drive Bio, Inc.
InventorsGregory L. VERDINE, M. James NICHOLS, Sharon A. TOWNSON, Uddhav Kumar SHIGDEL, Seung-Joo LEE, Dylan T. STILES, Neville J. ANTHONY
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods and reagents useful for analyzing protein-protein interfaces such as interfaces between a presenter protein (e.g., a member of the FKBP family, a member of the cyclophilin family, or PIN1) and a target protein. In some embodiments, the target and/or presenter proteins are intracellular proteins. In some embodiments, the target and/or presenter proteins are mammalian proteins.
Claims4
A compound having the structure:
- A-L-B,
- wherein A comprises a cyclophilin binding moiety having the structure of Formula IV:
- wherein Z3 and Z4 are each, independently, hydroxyl, optionally substituted C1-C6 alkyl, optionally substituted C1-C6 heteroalkyl, or Z3 and Z4 combine to form, with the atoms to which they are attached, an optionally substituted 10 to 40 member macrocycle;
- at least one of Z3, Z4, or R5 comprises a point of attachment to the cross-linking group;
- R5 is optionally substituted C1-C6 alkyl, optionally substituted C2-C6 alkenyl, optionally substituted C2-C6 alkynyl, optionally substituted C1-C6 heteroalkyl, optionally substituted C2-C6 heteroalkenyl, optionally substituted C2-C6 heteroalkynyl, optionally substituted C3-C10 carbocyclyl, optionally substituted C6-C10 aryl, optionally substituted C6-C10 aryl C1-C6 alkyl, optionally substituted C2-C9 heterocyclyl, or optionally substituted C2-C9 heterocyclyl C1-C6 alkyl;
- R6 is optionally substituted C1-C6 alkyl;
- L is a linker having the structure:
- A1-(B1)f—(C1)g—(B2)h-(D)-(B3)i—(C2)j—(B4)k-A2
- wherein A1 is a bond between the linker and the cyclophilin binding moiety;
- A2 is a bond between the cross-linking group and the linker;
- B1, B2, B3, and B4 each, independently, is selected from optionally substituted C1-C2 alkyl, optionally substituted C1-C3 heteroalkyl, O, S, and NRN;
- RN is hydrogen, optionally substituted C1-4 alkyl, optionally substituted C2-4 alkenyl, optionally substituted C2-4 alkynyl, optionally substituted C2-6 heterocyclyl, optionally substituted C6-12 aryl, or optionally substituted C1-7 heteroalkyl;
- C1 and C2 are each, independently, selected from carbonyl, thiocarbonyl, sulphonyl, or phosphoryl;
- f, g, h, I, j, and k are each, independently, 0 or 1;
- and D is optionally substituted C1-10 alkyl, optionally substituted C2-10 alkenyl, optionally substituted C2-10 alkynyl, optionally substituted C2-6 heterocyclyl, optionally substituted C6-12 aryl, optionally substituted C2-C10 polyethylene glycol, or optionally substituted C1-10 heteroalkyl, or a chemical bond linking A-(B1)f—(C1)g—(B2)h— to —(B3)i—(C2)j—(B4)k-A2;
- and
- B comprises a cross-linking group, wherein the cross-linking group is a mixed disulfide, maleimide, vinyl sulfone, vinyl ketone, alkyl halide, isocyanate, isothiocyanate, sulfonyl chloride, acid halide, active ester, acid anhydride, acylazide, imidoester, haloheteroaryl, diazo compound, carbodiimide, hydrazide, alkoxyamine, azide, or alkyne.
14 more elements
Dependencies are inferred from the claim text.